Clinical trial registry record

Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 20, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07184047
Last registry update
February 20, 2026
Status
Completed
Phase
Phase not reported
Sponsor
Ankara Etlik City Hospital
Enrollment
72
Countries
Turkey (Türkiye)
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
OBSERVATIONAL
Evidence population
Human clinical study registration
Participants
72
Population
ALL · 65 Years
Duration
2024-01-15 to 2026-02-19
Intervention
Adjuvant Chemotherapy (Standard of Care)
Comparator
Not reported
Outcomes measured
Predictive Value of the Geriatric-8 (G8) and the Vulnerable Elders Survey-13 (VES-13) Frailty Scales for Chemotherapy-R…; Correlation of Frailty Scores with the Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (S…; Correlation of Frailty Scores with the Mini Nutritional Assessment - Short Form (MNA-SF) Questionnaire — Baseline, 3 mo…; Correlation of Frailty Scores with the Katz Index of Activities of Daily Living (ADL) — Baseline, 3 months after chemot…; Correlation of Frailty Scores with the Lawton-Brody Instrumental Activities of Daily Living (IADL) Scale — Baseline, 3…; Correlation of Frailty Scores with the Eastern Cooperative Oncology Group (ECOG) Performance Status — Baseline, 3 month…; Overall Survival (OS) — 12 months after chemotherapy initiation; Progression-Free Survival (PFS) — 12 months after chemotherapy initiation.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Frailty · 100%Title contains controlled term: frailty. Abstract contains controlled term: frailty. Source terminology contains: frailty. Title supplies longevity context: frailty, frail. Study type is explicitly identified as OBSERVATIONAL.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

frailty
Open primary sourceExport JSON